Ashwagandha for Stress Reduction

Now enrolling!

Canva Design DAE--pg1p_g

Who can join?

You can join this study if you are an otherwise healthy female aged 30 - 59 with high levels of stress. You will need to be within driving distance of one of our pickup centers in the Southeast United States. 

Canva Design DAE--pg1p_g

What's involved?

You'll take an herbal supplement each day for 2 months. At the start and end of the study, you will taken an online survey and you will also spit into a tube so we can measure your cortisol levels. 

 

 

 

Canva Design DAE--pg1p_g

Will I be paid?

Yes! Our team compensates for your participation. You will receive a total of $120 if you complete the trial. Payments are sent 2-4 weeks after the end of the study. 

 

What are the steps?

Getting Started

To join the study, complete the form below. Our research team will send you an email with a survey for our team to learn more about your health status. If our team decides this study is a good fit, you will be reached out to schedule receiving your supply of capsules, as well as a start date. Our team will be available to make sure all your questions are answered. 

 

One

During the Study

While you are in the study, you will take your assigned product once a day for 60 days. At the start and end of the study, you will also take an online survey and spit into a tube so we can measure your cortisol.

Two

Payment & Support

Our team is available to you 24/7 during the study. You can reach out at any time with questions. 

Payment is sent via Tango Card in e-gift cards that can be used at over 100 popular American retailers or for a cash card. You will receive $120 for completing this study. Please note: Payments are only sent if all steps in the study have been completed. 

Three

To join this trial, fill out the form below:
Important Info

The purpose of this study is to measure the effects of an ashwagandha product on stress and cortisol levels.The protocol has been evaluated and approved by an independent third-party ethical review board which is accredited by the US Department of Health and Human Services (HHS) Office of Human Research Protections (OHRP). It is conducted in compliance with the Declaration of Helsinki, the Belmont Report, the regulations outlined in 45 CFR 46, and ICH GCP E6 (R2). The protocol is also registered at a World Health Organization (WHO) approved clinical trial registry.